131 related articles for article (PubMed ID: 31296419)
21. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
[TBL] [Abstract][Full Text] [Related]
22. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer.
Joslyn SA; Konety BR
Urology; 2006 Jul; 68(1):121-5. PubMed ID: 16806432
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan.
Morizane S; Honda M; Fukasawa S; Komaru A; Inokuchi J; Eto M; Shimbo M; Hattori K; Kawano Y; Takenaka A
Int J Clin Oncol; 2018 Jun; 23(3):568-575. PubMed ID: 29230586
[TBL] [Abstract][Full Text] [Related]
24. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
Heidenreich A; Ohlmann CH; Polyakov S
Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
26. Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).
Osarogiagbon RU; Decker PA; Ballman K; Wigle D; Allen MS; Darling GE
Ann Thorac Surg; 2016 Aug; 102(2):363-9. PubMed ID: 27262908
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
28. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
29. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
[TBL] [Abstract][Full Text] [Related]
30. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
[TBL] [Abstract][Full Text] [Related]
31. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032
[TBL] [Abstract][Full Text] [Related]
32. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.
Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH
J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037
[TBL] [Abstract][Full Text] [Related]
33. Single Positive Lymph Node Prostate Cancer Can Be Treated Surgically without Recurrence.
Kim DK; Koo KC; Abdel Raheem A; Kim KH; Chung BH; Choi YD; Rha KH
PLoS One; 2016; 11(3):e0152391. PubMed ID: 27031340
[TBL] [Abstract][Full Text] [Related]
34. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
35. Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count.
Giuliani A; Caporale A; Corona M; Di Bari M; Demoro M; Ricciardulli T; Gozzo P; Galati G; Tocchi A
J Exp Clin Cancer Res; 2004 Jun; 23(2):215-24. PubMed ID: 15354405
[TBL] [Abstract][Full Text] [Related]
36. Rate of Symptomatic Lymphocele Formation After Extraperitoneal vs Transperitoneal Robot-Assisted Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy.
Horovitz D; Lu X; Feng C; Messing EM; Joseph JV
J Endourol; 2017 Oct; 31(10):1037-1043. PubMed ID: 28741376
[TBL] [Abstract][Full Text] [Related]
37. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.
Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Montorsi F; Saad F; Briganti A; Steuber T; Budäus L; Huland H; Graefen M; Tilki D; Karakiewicz PI
Urol Oncol; 2018 Aug; 36(8):365.e1-365.e7. PubMed ID: 29887241
[TBL] [Abstract][Full Text] [Related]
38. Lymph node-positive prostate cancer after robotic prostatectomy and extended pelvic lymphadenectomy.
Chenam A; Parihar JS; Ruel N; Pal S; Avila Y; Yamzon J; Lau C; Yuh B
J Robot Surg; 2018 Sep; 12(3):425-431. PubMed ID: 28905289
[TBL] [Abstract][Full Text] [Related]
39. Extent of Lymphadenectomy at Time of Prostatectomy: An Evidence-Based Approach.
Vollstedt A; Hyams E
Urol Clin North Am; 2017 Nov; 44(4):587-595. PubMed ID: 29107275
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymphadenectomy compared to extended lymphadenectomy in men with prostate cancer undergoing prostatectomy.
Ponholzer A; Lamche M; Klitsch M; Kraischits N; Hiess M; Schenner M; Brossner C; Schramek P
Anticancer Res; 2012 Mar; 32(3):1033-6. PubMed ID: 22399628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
